Graphical abstract Similar content being viewed by others Introduction Over the past decade, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated cardiovascular, renal, and metabolic benefits in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) or high cardiovascular (CV) risk, and have subsequently been incorporated into multiple international guidelines [1,2,3]
The team consists of: Jennifer Smallridge (Exercise Physiologist) Sarah Lynch (Physiotherapist, Yoga Teacher) Jade Brodie (Physiotherapist, Hand Therapist) Together they bring expertise in chronic illness care coordination, safe exercise & movement support, pacing and fatigue management, chronic pain education, coaching and goal setting
It delivers a supportive boost designed to work in harmony with balanced lifestyle habits and nutritional goals
see the reconstitution section above for the math
Missing doses or irregular timing disrupts this accumulation
